NASDAQ: MENS
Jyong Biotech Ltd Stock Ownership - Who owns Jyong Biotech?

Insider buying vs selling

Have Jyong Biotech Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MENS insiders and whales buy or sell their stock.

MENS Shareholders

What type of owners hold Jyong Biotech Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fufeng Kuo33.34%25,349,500$51.97MInsider
Blackrock Inc0.34%258,760$530.46kInstitution
Geode Capital Management LLC0.08%64,232$131.68kInstitution
Ubs Group Ag0.05%37,363$76.59kInstitution
Millennium Management LLC0.02%14,590$29.91kInstitution
Vanguard Personalized Indexing Management LLC0.02%13,927$28.55kInstitution
China Universal Asset Management Co Ltd0.02%13,173$27.00kInstitution
Hrt Financial LP0.02%11,767$24.12kInstitution
Tower Research Capital LLC Trc0.02%11,703$23.99kInstitution
Morgan Stanley0.01%6,301$12.92kInstitution

1 of 2

MENS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MENS0.60%33.35%
IPHA0.20%0.00%
TNYA25.03%38.16%Net SellingNet Selling
PYXS43.52%37.01%Net BuyingNet Buying
CRBP46.35%53.65%Net SellingNet Buying

Jyong Biotech Stock Ownership FAQ

Who owns Jyong Biotech?

Jyong Biotech (NASDAQ: MENS) is owned by 0.60% institutional shareholders, 33.35% Jyong Biotech insiders, and 66.05% retail investors. Fufeng Kuo is the largest individual Jyong Biotech shareholder, owning 25.35M shares representing 33.34% of the company. Fufeng Kuo's Jyong Biotech shares are currently valued at $56.28M.

If you're new to stock investing, here's how to buy Jyong Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.